Water Ways Technologies Inc. (formerly Sagittarius Capital Corporation) (NEX Board: SCX.H) (“Water Ways” or the “Company”), is pleased to announce further to its press releases dated December 31, 2018, August 27, 2018 and June 27, 2018, that it has closed its previously announced Qualifying Transaction (“QT”) with Irri-Al-Tal Ltd. (“IAT”) a company incorporated under the laws of Israel. In addition, aggregate gross proceeds totalling $3,109,570 was raised in connection with the QT, of which $2,818,125 was raised via public offering (“Offering”) of units (“Units”) of Water Ways and $291,445 by way of a private placement (“Concurrent Private Placement”) of units of IAT (“IAT Units”).

Ohad Haber, President, CEO and Director of Water Ways commented: “We are very pleased to announce the completion of the financing and securities exchange with Sagittarius and look forward entering this new chapter of our company. As a global leader in providing innovative irrigation equipment and irrigation turnkey solutions, this financing positions us to pursue opportunities in new markets and new product and service verticals. We also expect that becoming a public company will provide us with additional credibility on the global stage in order to attract additional financing to aggressively accelerate our sales. We thank everyone who made this milestone possible and look forward to demonstrating the full potential of Israeli innovation in the irrigation sector”.


Adam Szweras, Director and Corporate Secretary of Water Ways, and Chairman of the Company’s financial advisor FMI Capital Advisory Inc., added: “Our firm has worked with Water Ways for over a year now and we are excited about the growth prospects in its traditional markets and with legal cannabis and hemp cultivators. We look forward to continue working with management in this new phase of the Company’s existence to seize the opportunity for continued rapid growth”.

Qualifying Transaction

The QT provided for the acquisition of all of the outstanding equity interests of IAT by Water Ways in a transaction in which the shareholders of IAT received common shares of Water Ways (the “Common Shares”) and, in case of outstanding convertible securities of IAT, convertible securities of Water Ways. Shareholders of IAT were issued an aggregate of 75,338,152 Common Shares (the “Consideration Shares”) based on the deemed value ascribed to IAT as negotiated between Water Ways and IAT of approximately CAD $18.8 million, at a deemed issue price of CAD$0.25, resulting in 2 Consideration Shares for each one IAT share held. As a result of the QT, Water Ways became the sole beneficial owner of all of the outstanding securities of IAT. Water Ways is the parent company of IAT which will continue its business.

Prior to the QT, Water Ways was a Capital Pool Company (as defined under the policies of the TSX Venture Exchange (the “Exchange”)) and had not commenced commercial operations and had no assets other than cash. The QT constituted Water Ways’ “Qualifying Transaction”, as such term is defined in Policy 2.4 of the Exchange. In connection with the QT the Company’s name was changed from Sagittarius Capital Corporation to Water Ways Technologies Inc. and its shares were consolidated on the basis of one post-consolidation share for every 1.4964285 pre-consolidation shares.

Final acceptance of the QT will occur upon the issuance of a Final Exchange Bulletin by the Exchange. Upon issuance of the Final Exchange Bulletin, Water Ways will cease to be a Capital Pool Company and will recommence trading on the Exchange as a Tier 1 issuer. Subject to this final acceptance, trading in the common shares of Water Ways is expected to begin on the Exchange under the symbol “WWT” shortly. A further press release will be issued when the date trading is anticipated to commence is known.

Public Offering and Concurrent Private Placement

In connection with the QT, Water Ways completed an Offering of 11,272,500 Units for gross proceeds of $2,818,125. Each Unit is comprised of one Common Share and one-half of one common share purchase warrant (each whole warrant, a “Warrant”) of Water Ways at a price of $0.40 per Unit, for a total issuance of 11,272,500 Common Shares and 5,636,250 Warrants. Each Warrant is exercisable into one Common Share (a “Warrant Share”) at $0.40 per Warrant Share until March 6, 2021. If the closing price of the Common Shares on the Exchange is equal to or greater than $0.75 for any 20 consecutive trading days, the Company may, upon providing written notice to the holders of the Warrants, accelerate the expiry date of the Warrants to the date that is 30 days following the date of such written notice.

The Offering was conducted by Leede Jones Gable Inc. (“Leede”) as lead agent and sole bookrunner. As consideration for acting as agent for the Offering, Leede received: (i) a cash commission of $225,450; (ii) a corporate finance fee of $40,000; and (iii) 901,800 non-transferable broker warrants (each, a “Broker Warrant”). Each Broker Warrant entitles the holder to one Common Share at a price of $0.50 until March 6, 2021.

Immediately prior to the closing of the QT, IAT completed a non-brokered Concurrent Private Placement of IAT Units raising gross proceeds of $291,445.38. Each IAT Unit was issued at a price of $0.50 and was comprised of one ordinary share in the capital of IAT and one-half of one ordinary share purchase warrant. Each whole warrant entitled the holder thereof to acquire one ordinary share at a price of $0.80 per share until March 5, 2021. The securities issued in connection with this private placement were converted into Common Shares and warrants of Water Ways, respectively, in connection with the QT with such conversion being completed on the same two to one exchange ratio referenced above.

As a result of the QT and the Offering, Water Ways has 89,410,652 Common Shares issued and outstanding, with 84.3% held by former IAT shareholders (of which 1.3% of the total is attributed to the participants of the Concurrent Private Placement), 3.1% held by shareholders of Water Ways who were shareholders prior to the QT and 12.6% held by purchasers of the Units. In addition there are 11,219,141 common share purchase warrants issued and outstanding, of which 5,636,250 are Warrants held by the participants in Offering, and 5,582,891 are the warrants held by former IAT warrant holders. In addition, there are 1,701,800 broker warrants outstanding, of which 901,800 represents the Broker Warrants and the balance represents the consideration compensation options issued in connection with IAT’s previous financings.

Pursuant to the terms of an escrow agreement among Water Ways, TSX Trust Company and certain escrowed security holders, an aggregate of 60,606,150 Common Shares, 145,872 warrants and 552,714 brokers options have been placed in escrow, which will be released in tranches over the next 18 months, with the first release upon issuance of the Exchange’s Final Exchange Bulletin pursuant to the Tier 1 issuer escrow requirements.

As a result of the closing of the QT, the directors and officers of Water Ways are now:

Ohad Haber – Director and CEO
Meira Zada – CFO
Ronnie Jaegermann – Director
Yehuda Doron – Director
James Lanthier – Director
Adam Szweras – Director and Corporate Secretary

Further details about the QT, the Offering and Water Ways are available in the final prospectus of Water Ways dated December 27, 2018 filed in respect of the QT which has been filed under Water Ways’ profile on SEDAR at www.sedar.com.

Fogler Rubinoff LLP acted as legal counsel to Water Ways, Gowling WLG (Canada) LLP and Adv. Yaniv Bresler (Israel) acted as legal counsel to IAT and Burnet, Duckworth & Palmer LLP acted as legal counsel for Leede.

Early Warning

Ohad Haber, an officer and director of Water Ways, held 28,500,000 IAT ordinary shares. Upon completion of the QT, Mr. Haber now beneficially owns and has control over 57,000,000 Common Shares representing approximately 63.7% of the issued and outstanding Common Shares.

Immediately before the QT, Mr. Haber held, directly or indirectly, beneficial ownership of, or the power to exercise control or direction over, no Common Shares. Immediately after the QT, Mr. Haber held, directly or indirectly, beneficial ownership of, or the power to exercise control or direction over, 57,000,000 Common Shares, representing 63.7% of all of the issued and outstanding common shares of Water Ways.

The Common Shares were acquired for investment purposes. Mr. Haber may increase or reduce his investments in Water Ways according to market conditions or other relevant factors.

The foregoing disclosure regarding Mr. Haber’s holdings is being disseminated pursuant to National Instrument 62-103 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues. A copy of the report to be filed with Canadian securities regulators in connection with the acquisition of these securities can be obtained under Water Ways’ profile on the SEDAR website (www.SEDAR.com) or by contacting the Mr. Haber c/o Meira Zada, meira@irri-altal.com.

About Water Ways Technologies

Water Ways is the parent company of IAT which is an Israeli based agriculture technology company that specializes in providing water irrigation solutions to agricultural producers. IAT competes in the global irrigation water systems market with a focus on developing solutions with commercial applications in the micro and precision irrigation segments of the overall market. At present, IAT’s main revenue streams are derived from the following business units: (i) Projects Business Unit; and (ii) Component and Equipment Sales Unit. IAT was founded in 2003 by Mr. Ohad Haber with a view of capitalizing on the opportunities presented by micro and smart irrigation, while also making a positive mark on society by making these technologies more widely available, especially in developing markets such as Africa and Latin America. IAT’s past projects include vineyards, water reservoirs, fish farms, fresh produce cooling rooms and more, in over 15 countries.

Forward-Looking Statements

Certain statements contained in this press release constitute “forward-looking information” as such term is defined in applicable Canadian securities legislation. The words “may”, “would”, “could”, “should”, “potential”, “will”, “seek”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions as they relate to Water Ways, including receipt of the Final Exchange Bulletin and the proposed listing date, are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect Water Ways’ current views and intentions with respect to future events, and current information available to Water Ways, and are subject to certain risks, uncertainties and assumptions. Material factors or assumptions were applied in providing forward-looking information, including: the Exchange is satisfied with the final listing materials submitted by Water Ways and issues its Final Exchange Bulletin and approves trading. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. Should any factor affect Water Ways in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, Water Ways does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and Water Ways undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law. Water Ways’ results and forward-looking information and calculations may be affected by fluctuations in exchange rates. All figures are in Canadian dollars unless otherwise indicated.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Source: www.newswire.ca

Cannabis Market Update: Q3 2020 in Review

Click here to read the previous cannabis market update.

During the first few months of investment time in 2021, cannabis faced some volatility alongside optimism about federal changes in the most important market for the drug.

The cannabis business found its stride during Q1 thanks to policy change signals and consolidation.

To find out more, the Investing News Network (INN) asked experts about progress in the market during the first major period of the new year, and which developments investors should watch out for.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Cannabis market update: New York and US potential boost operations

New York state’s legalization of recreational cannabis was a huge Q1 announcement that added pressure to the US federal government when it comes to cannabis policy, said George Mancheril, co-founder and CEO of Bespoke Financial, a debt financing business with a particular focus on servicing cannabis businesses.

“It’s going to add to the chorus of voices in the federal scene to basically move sooner rather than later,” he explained to INN.

Following the US election in 2020, the momentum for cannabis businesses went on the upswing, as did company valuations, with the idea of expansion at the heart of it all, according to Mancheril.

Before starting Bespoke Financial, Mancheril learned from traditional investment banks, working in the lending, fixed income and debt markets with Goldman Sachs (NYSE:GS) and Guggenheim Partners.

Nawan Butt, portfolio manager with Purpose Investments, agrees with Mancheril. The financial expert told INN the ongoing legalization process seen in the US market is leading to expansion.

“It’s becoming more of a national move, then small pockets of proliferation. That’s very exciting about cannabis right now,” said Butt, who co-manages the Purpose Marijuana Opportunities Fund (NEO:MJJ).

This proliferation effect is causing a change in valuations and enthusiasm for US-based operations. Mancheril told INN that by the end of Q1, multi-state operators (MSOs) had raised approximately US$3.3 billion.

The cannabis lender said he sees the industry as having grown from the woes of 2019; it is now undergoing a return to form as excitement about the US opening up increases.

The expert explained that there is likely to be a windfall of capital in the wake of major federal changes in US cannabis policy, although the timeline for these changes is becoming increasingly hard to predict.

Leading up to that capital influx, Mancheril said he wants to see operators really drill down on the value of desired assets and whether they make sense.

“What I’d hope is that we continue to see bullish sentiment, but with some measure of responsibility, and let’s not just get over ahead of ourselves,” Mancheril told INN. “The idea is let’s minimize the volatility and continue growing responsibly.”

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

As far as struggles go, Butt explained that the cannabis industry has cemented itself as a growth-type sector, and as such there are macro pressures affecting the way these assets operate.

“We’ve seen this preference for cash flows at growth in the current or in the near future, rather than in the far future, and that’s what we’re seeing as far as valuations go in the broad market,” Butt said.

Cannabis market update: Volatility continues to rule as industry foundations build

Despite the industry’s potential and the growing pains it has gone through as a whole in both the US and Canada, volatility remains a key factor in the cannabis investment scene.

Butt explained that the current shareholder base, which is dominated by hedge funds and retail investors, still lacks enough institutional support to avoid the day-to-day volatility cannabis has come to be known for.

These two investor groups, Butt said, can be easily spooked and excited by the news of the day when it comes to their investments.

“A lot of these institutions’ strategies are not about short-term profits, but they’re about long-term sustainability of the businesses themselves,” Butt said.

“That’s why you see a lot of volatility in the space, and that’s essentially what we’ve seen over the past, I’d say, three to two months as well,” he added.

That means investors shouldn’t expect an end to volatility anytime soon.

“It’s not about whether we continue to expect volatility, because we do,” Butt said. “We really think that the volatility will be taken out when the shareholder base becomes more institutional, but it’s really about understanding why there is volatility in the first place.”

Cannabis market update: Canadians talk up US business, but questions remain

A surge of mergers and acquisitions has taken over the Canadian cannabis sector recently as more producers see potential in America.

One of the biggest announcements in this regard came when Organigram Holdings (NASDAQ:OGI,TSX:OGI) secured a C$221 million investment deal from British American Tobacco (NYSE:BTI,LSE:BATS).

Using the funds, the two will work in tandem to develop new branded products designed for the international stage, including in the US. Organigram CEO Greg Engel previously told INN that the US represents a critical opportunity for Canadian companies, but the entry point isn’t as clean as it could be.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

While the long-term potential may be exciting for investors, Butt told INN he’s still unsure how the approach will work for Canadian companies.

The Purpose Investments expert said there will be plenty of space for the biggest Canadian names to pursue US market entries, beyond the initial hemp-derived CBD moves some operators have mde, since the US represents the biggest market in the world.

“But there’s just way too many unknowns right now to say exactly what that participation is going to look like, or when that participation will happen,” he said.

“What we do know is that currently the US MSOs are in a wonderful sort of position to expand on their market leadership that they have. And it will be tough for Canadians to come in and compete with them,” Butt said.

Canadian players still retain the upper hand at times in terms of valuation, which is confusing for both Butt and Dan Ahrens, chief operating officer and portfolio manager at AdvisorShares.

“The performance in quarterly earnings of US companies has been rather spectacular. They’ve knocked it out of the park in most instances,” Ahrens told INN.

Butt praised the recent performance reports from MSOs across the board, pointing to year-over-year growth lines and projections for continued positive performance. In his view, share prices still don’t reflect company value. “Those are really being discounted at this point,” Butt told INN.

“We’ve seen the Canadian licensed producers be really hot stock performance-wise, outpacing the US (MSOs), and I’ll say it’s rather nonsensical to me,” said Ahrens, who oversees the AdvisorShares Pure Cannabis ETF (ARCA:YOLO) and the recently launched AdvisorShares Pure US Cannabis ETF (ARCA:MSOS).

Cannabis market update: Investor takeaway

The cannabis investment proposition finds itself at an interesting moment in time, as the entire sector eagerly awaits confirmation in the US at the federal level.

While for the Canadian companies waiting on the sidelines, this development may feel like a major necessity to address current financial struggles, for US-based operators, the heat around the corner could represent future positivity for already thriving operations.

Keep reading... Show less

 Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States will release its first quarter 2021 financial results on Thursday, May 13, 2021 before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

All interested parties can join the conference call by dialing 1-888-231-8191 or 1-647-427-7450, conference ID: 4880609. Please dial in 15 minutes prior to the call to secure a line. The conference call will be archived for replay until May 20, 2021 . To access the archived conference call, please dial 1-855-859-2056 and enter the encore code 4880609.

Keep reading... Show less

Appointment of Dr. Kelmendi, Assistant Professor of Psychiatry at Yale University and co-founder of the Yale Psychedelic Science Group, brings another experienced medical professional to Lobe’s advisory team.

 Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the appointment of Benjamin Kelmendi, MD, Assistant Professor of Psychiatry at Yale University School of Medicine, to its Scientific Advisory Board.

Keep reading... Show less

Ayurcann Holdings Corp. ( CSE: AYUR ) (the “ Company ” or ” Ayurcann “), a Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, is pleased to unveil further details of its Phase 2 expansion plans.

Ayurcann has commenced trading on the Canadian Securities Exchange (” CSE “) on April 8, 2021 and subsequently announced a private placement of up to $500,000 (” Financing “), as per the Company’s press release dated April 12, 2021. The proceeds of the Financing are intended to be used to further pursue Phase 2 of the expansion of the production capacity of the Company’s Pickering facility.

Keep reading... Show less